128 related articles for article (PubMed ID: 15621309)
21. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
22. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
23. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus.
Fernandez-Blanco L; Perez-Pampin E; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2004 Jan; 50(1):328-9. PubMed ID: 14730632
[No Abstract] [Full Text] [Related]
24. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
[TBL] [Abstract][Full Text] [Related]
26. Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model.
Campbell SE; Bennett D; Nasir L; Gault EA; Argyle DJ
Rheumatology (Oxford); 2005 Jun; 44(6):735-43. PubMed ID: 15757961
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
29. [Lupus in the dog for a better understanding of human lupus].
Monier JC
Pathol Biol (Paris); 1981 May; 29(5):261-4. PubMed ID: 7015253
[No Abstract] [Full Text] [Related]
30. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
31. Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptor.
Mihaylova N; Voynova E; Tchorbanov A; Nikolova M; Michova A; Todorov T; Srebreva L; Taskov H; Vassilev T
Int Immunol; 2008 Feb; 20(2):165-75. PubMed ID: 18156625
[TBL] [Abstract][Full Text] [Related]
32. Lupus: mysterious disease holds its secrets tight.
Marshall E
Science; 2002 Apr; 296(5568):689-91. PubMed ID: 11976440
[No Abstract] [Full Text] [Related]
33. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
37. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
38. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
Kozyrev SV; Abelson AK; Wojcik J; Zaghlool A; Linga Reddy MV; Sanchez E; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Pons-Estel BA; Witte T; D'Alfonso S; Barizzone N; Danieli MG; Gutierrez C; Suarez A; Junker P; Laustrup H; González-Escribano MF; Martin J; Abderrahim H; Alarcón-Riquelme ME
Nat Genet; 2008 Feb; 40(2):211-6. PubMed ID: 18204447
[TBL] [Abstract][Full Text] [Related]
39. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
40. Mouse monoclonal autoantibodies penetrate mouse macrophage cells and stimulate NF-kappaB activation and TNF-alpha release.
Jang EJ; Nahm DH; Jang YJ
Immunol Lett; 2009 Jun; 124(2):70-6. PubMed ID: 19394364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]